Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Eron

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2020
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled AnalysisJoseph Eron, Chien-Ching Hung, Jean-Guy Baril, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Frontiers in Cellular and Infection Microbiology|February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed PatientsGeoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
AIDS (London, England)|April 8, 2021
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxisRogers Sekabira, Ian McGowan, Krista Yuhas, et al.
The Journal of Infectious Diseases|April 22, 2026
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
AIDS (London, England)|December 21, 2022
The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuumRaynell Lang, Brenna Hogan, Jiafeng Zhu, et al.
Epidemiology (Cambridge, Mass.)|February 16, 2021
HIV Viremia and Risk of Stroke Among People Living with HIV Who Are Using Antiretroviral TherapyBarbara N Harding, Tigran Avoundjian, Susan R Heckbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
End-stage renal disease among HIV-infected adults in North AmericaAlison G Abraham, Keri N Althoff, Yuezhou Jing, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2020
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled AnalysisJoseph Eron, Chien-Ching Hung, Jean-Guy Baril, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Frontiers in Cellular and Infection Microbiology|February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed PatientsGeoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
AIDS (London, England)|April 8, 2021
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxisRogers Sekabira, Ian McGowan, Krista Yuhas, et al.
The Journal of Infectious Diseases|April 22, 2026
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
AIDS (London, England)|December 21, 2022
The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuumRaynell Lang, Brenna Hogan, Jiafeng Zhu, et al.
Epidemiology (Cambridge, Mass.)|February 16, 2021
HIV Viremia and Risk of Stroke Among People Living with HIV Who Are Using Antiretroviral TherapyBarbara N Harding, Tigran Avoundjian, Susan R Heckbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
End-stage renal disease among HIV-infected adults in North AmericaAlison G Abraham, Keri N Althoff, Yuezhou Jing, et al.
Pageof 7